I found this write up in Born2Invest that talks about NG Biotech COVID test.
https://born2invest.com/articles/ng-biotech-test-coronavirus-infection/
Interesting read - one thing that stood out is NG Biotech seem to be ready to do 6 million tests in 6 months. This coincides with AT1 plan to increase capacity of their units to 6 million by August.
Have they already signed up to sell the 6 million? NG Biotech have doubled their staff to increase capacity.
If AT1 sell 6million units to NG Biotech, then we are looking at valuation over $1/share pretty soon.
Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-13
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $19.17M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.2¢ | 3.0¢ | $8.801K | 290.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 130819 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 210699 | 3 |
View Market Depth
| Last trade - 15.20pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
3.0¢ |
Change
-0.001 ( 3.23 %) |
||||
| Open | High | Low | Volume | ||
| 3.1¢ | 3.1¢ | 3.0¢ | 60875 | ||
| Last updated 15.20pm 25/04/2024 ? | |||||
| AT1 (ASX) Chart |